ストックスクリーナーアプリを入手
8.86
1.01%
-0.09
前日終値:
$8.95
開ける：
$9.1
24時間の取引高:
2,794
Relative Volume:
0.41
時価総額：
$601.02M
収益：
$277.56M
当期純損益:
$-13.33M
株価収益率:
-46.63
EPS:
-0.19
ネットキャッシュフロー:
$-6.54M
1週間 パフォーマンス:
-3.70%
1か月 パフォーマンス:
-7.23%
6か月 パフォーマンス:
+8.35%
1年 パフォーマンス:
-20.46%
1日の値動き範囲:
$8.81
$9.1999
1週間の範囲:
$8.50
$9.50
52週間の値動き範囲:
$6.65
$12.20
Pharming Group N V Adr Stock (PHAR) Company Profile
PHAR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PHAR
Pharming Group N V Adr
|
8.86 | 601.02M | 277.56M | -13.33M | -6.54M | -0.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Pharming Group N V Adr Stock (PHAR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-09 | 開始されました | Jefferies | Buy |
Pharming Group N V Adr (PHAR) 最新ニュース
Pharming Group to participate in February investor conference - GlobeNewswire Inc.
Pharming Group (OTCMKTS:PHGUF) Shares Cross Above 50 Day Moving Average – Time to Sell? - Defense World
Pharming Group stock gains on KL1333’s blockbuster potential, says RBC - Investing.com India
H.C. Wainwright reiterates Buy on Pharming stock, pediatric trial shows safety and tolerability - Investing.com India
Jefferies initiates Pharming Group shares with Buy on revenue growth - Investing.com India
Oppenheimer cuts Pharming Group stock target, Outperform on Q3 results - Investing.com India
Earnings call: Pharming Group NV reports growth amid CEO transition - Investing.com
Earnings call: Pharming Group NV sees robust growth in Q3, CEO to step down - Investing.com
October 2024's Promising Penny Stocks to Watch - Yahoo Finance
Novavax (NVAX) Moves 19.2% Higher: Will This Strength Last? - Yahoo Finance
Earnings call: Pharming Group reports robust growth and pipeline expansion - Investing.com
Pharming (PHAR) Rare Disease Drug Joenja Gets FDA Nod, Stock Up - Nasdaq
Can Pharming Group N.V. Sponsored ADR (PHAR) Run Higher on Rising Earnings Estimates? - Zacks Investment Research
PHARM Stock Price and Chart — EURONEXT:PHARM - TradingView
Pharming Group N V Adr (PHAR) 財務データ
収益
当期純利益
現金流量
EPS
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):